loader image

Mon, Mar 31 | 1:19 pm

30% of Schiphol Flights Contribute Minimally to the Dutch Economy

by | Apr 2, 2024

A recent study reveals that nearly a third of flights taking off and landing at Schiphol contribute little to the Dutch economy. Researchers highlight that the economic benefits of many flights, especially transfers, outweigh the damage to public health and the environment caused by noise pollution and nitrous oxide emissions. Commissioned by the environmental organization Natuur & Milieu, the study comes at a time when the government aims to reduce the number of flights at the airport by 10% to just over 450,000 per year.

The outgoing cabinet’s proposed plans to reduce flight capacity face resistance from the domestic aviation industry and airlines from other countries, particularly the US. The US Department of Transportation has objected to the reduction of space for US airlines at Schiphol, particularly the exclusion of JetBlue. The threat of retaliatory measures is looming, escalating tensions between the two countries.

JetBlue, one of the 24 airlines operating at Schiphol since last summer, is among those affected. The denial of slots for the upcoming year has further heightened tensions. Meanwhile, KLM has warned of the consequences of forced downsizing, potentially impacting its transatlantic cooperation with key partners.

0 Comments

text

 

 

 

 

 

 

text

 

 

 

 

 

 

Related Posts

McIlroy Joins Elite Company with $100M PGA Tour Earnings

McIlroy Joins Elite Company with $100M PGA Tour Earnings

Rory McIlroy has officially joined one of the most exclusive clubs in professional golf. The Northern Irishman became just the second player in PGA Tour history to earn over $100 million in career prize money, following in the footsteps of golf legend Tiger Woods....

Drugmakers Tumble After Top FDA Vaccine Chief Steps Down

Drugmakers Tumble After Top FDA Vaccine Chief Steps Down

The sudden resignation of Dr. Peter Marks, the head of the FDA’s Center for Biologics Evaluation and Research, has sent shockwaves through the pharmaceutical and biotech industries. Dr. Marks, a central figure in the U.S. vaccine rollout during the COVID-19 pandemic,...